Trade Agreement: Agreement on Internal Trade (AIT)
Tendering Procedures: Generally only one firm has been invited
to bid
Attachment: None
Non-Competitive Procurement Strategy: Exclusive Rights
Comprehensive Land Claim Agreement: No
Vendor Name and Address:
Pfizer Canada Inc
Pfizer Canada Inc.
17300 Trans-Canada Highway
Kirkland Quebec
Canada
H9J2M5
Nature of Requirements:
Requirement
PWGSC proposes to contract with Pfizer Canada Inc. for the
purchase of 751,836 doses of Prevnar® 13 (Pneumococcal Conjugate
vaccine 13 valent) on behalf of the Health Ministries of the
provinces of Alberta, Manitoba, New Brunswick, Newfoundland &
Labrador, Northwest Territories, Nova Scotia, Nunavut,
Ontario, Prince Edward Island, Saskatchewan and Yukon. This
requirement includes a federal portion of 5,980 doses on behalf
of Health Canada Alberta and The Department of National Defence.
Vaccine is to be supplied as and when requested from date of
award to March 31, 2015. In addition it is proposed to include
the option for three additional one year periods which, if
exercised, would end March 31, 2018.
Any resulting contract will include an option to add new users
and to increase the quantity up to 20% of the total estimated
requirement to accommodate the increased requirements of
existing users. Each consignee will be obligated to purchase
90% of their estimated requirement.
This requirement falls within the Federal/Provincial/Territorial
(F/P/T) Group Purchasing Program for Drugs and Vaccines.
Applicability of Trade Agreements
The provisions of the World Trade Organization Agreement on
Government Procurement (WTO-AGP), the North American Free Trade
Agreement (NAFTA), the Canada-Chile Free Trade Agreement (CCFTA)
and the Canada-Columbia Free Trade Agreement Canada - Peru Free
Trade (FTA) are not applicable for reasons connected with the
protection of human life and health (see NAFTA article 1018
para. 2 (a) and (b); WTO-AGP article XXIII (2); CCFTA article
Kbis-16 para. 2 (b); and FTA article 1402 para. 2 (b) ), and
because of the absence of regulatory harmonization between
Canada and the other signatory countries to the WTO, NAFTA,
CCFTA and FTA. This requirement is subject to the Agreement on
Internal Trade (AIT).
Limited Tendering Reason
Responsibility for health care delivery (including the purchase
of vaccines) lies with Provincial and Territorial governments.
Each Designated User in the F/P/T Group Purchasing Program has
specific needs and individual program delivery requirements.
It is proposed to negotiate this requirement directly with
Pfizer Canada Inc. on behalf of the noted Designated Users as
the Pfizer product is the only product that can be considered at
this time for the following reasons :
Jurisdictions are not in a position to consider an alternative
to Prevnar ® 13 because it is the only licensed Pneumococcal
Conjugate vaccine to cover 13 serotypes and be indicated for
infants and children less than 5 years in age;
Prevnar ® 13 provides the broadest available protection against
the maximum number of serotypes of pneumococcal disease.
Delivery Date: Above-mentioned
You are hereby notified that the government intends to negotiate
with one firm only as identified above. Should you have any
questions concerning this requirement, contact the contracting
officer identified above.
An Advance Contract Award Notice (ACAN) allows departments and
agencies to post a notice, for no less than fifteen (15)
calendar days, indicating to the supplier community that it
intends to award a good, service or construction contract to a
pre-identified contractor. If no other supplier submits, on or
before the closing date, a Statement of Capabilities that meets
the requirements set out in the ACAN, the contracting authority
may then proceed with the award. However, should a Statement of
Capabilities be found to meet the requirements set out in the
ACAN, then the contracting authority will proceed to a full
tendering process.
Suppliers who consider themselves fully qualified and available
to provide the services/goods described herein, may submit a
statement of capabilities in writing to the contact person
identified in this Notice on or before the closing date of this
Notice. The statement of capabilities must clearly demonstrate
how the supplier meets the advertised requirements.
The PWGSC file number, the contracting officer's name and the
closing date of the ACAN must appear on the outside of the
envelope in block letters or, in the case of a facsimile
transmission, on the covering page.
The Crown retains the right to negotiate with suppliers on any
procurement.
Documents may be submitted in either official language of Canada.
